{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:10:21Z","timestamp":1790514621200,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.encep.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T18:15:21Z","timestamp":1364840121000},"page":"S42-S48","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["R\u00e9introduction de la clozapine chez les patients souffrant de schizophr\u00e9nie r\u00e9sistante \u00ab\u00a0super r\u00e9pondeurs\u00a0\u00bb, apr\u00e8s neutrop\u00e9nie sous clozapine\u00a0: \u00e0 propos d\u2019un cas"],"prefix":"10.1016","volume":"39","author":[{"given":"G.","family":"Huguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lillo-Le Louet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Darnige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.O.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2013.02.003_bib0005","series-title":"Psychopharmacologie essentielle\/Le guide du prescripteur","author":"Stahl","year":"2007"},{"key":"10.1016\/j.encep.2013.02.003_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","article-title":"Haematological toxicity of drugs used in psychiatry","volume":"23","author":"Flanagan","year":"2008","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.encep.2013.02.003_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/026988119801200309","article-title":"Haematological safety of antipsychotic drugs","volume":"12","author":"King","year":"1998","journal-title":"J Psychopharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.encep.2013.02.003_bib0020","first-page":"3","article-title":"Reducing clozapine-related morbidity and mortality: 5\u00a0years of experience with the Clozaril National Registry","volume":"59","author":"Honigfeld","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.encep.2013.02.003_bib0025","first-page":"520","article-title":"Lithium treatment of clozapine induced neutropenia","volume":"31","author":"Esposito","year":"2005","journal-title":"Enc\u00e9phale"},{"issue":"6","key":"10.1016\/j.encep.2013.02.003_bib0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0013-7006(04)95473-5","article-title":"Treatment of clozapine-induced granulocytopenia with lithium","volume":"30","author":"Papetti","year":"2004","journal-title":"Enc\u00e9phale"},{"issue":"7","key":"10.1016\/j.encep.2013.02.003_bib0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1176\/appi.ajp.2008.07111823","article-title":"Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia","volume":"165","author":"Ghaznavi","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2013.02.003_bib0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1176\/appi.ajp.2008.08081295","article-title":"Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia\/agranulocytosis","volume":"166","author":"Joffe","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2013.02.003_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0447.1999.tb10851.x","article-title":"Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS)","volume":"100","author":"Lan\u00e7on","year":"1999","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.encep.2013.02.003_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay","year":"1988","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2013.02.003_bib0055","unstructured":"Dictionnaire VIDAL (86e edition); 2010."},{"key":"10.1016\/j.encep.2013.02.003_bib0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1192\/bjp.177.1.88","article-title":"Paradoxical pattern of haematological risk with clozapine","volume":"177","author":"Gillman","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12,760\u00a0clozapine recipients in the UK and Ireland. Beyond pharmacovigilance","volume":"175","author":"Munro","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2370.1998.00091.x","article-title":"HLA-B38\u00a0and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients","volume":"25","author":"Valevski","year":"1998","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.encep.2013.02.003_bib0075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","article-title":"HLA- B38, DR4, DQw3\u00a0and clozapine-induced agranulocytosis in Jewish patients with schizophrenia","volume":"47","author":"Lieberman","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v67n0509","article-title":"Lithium and clozapine rechallenge: a retrospective case analysis","volume":"67","author":"Kanaan","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.chi.0000171904.23947.54","article-title":"Hematological adverse events in clozapine-treated children and adolescents","volume":"44","author":"Gerbino-Rosen","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0195","series-title":"Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Fifteenth Edition)","author":"Aronson","year":"2006"},{"issue":"2","key":"10.1016\/j.encep.2013.02.003_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1600-0447.2000.102002153.x","article-title":"Granulocyte colony stimulating factor plasma levels during clozapine and olanzapine induced granulocytopenia","volume":"102","author":"Schuld","year":"2000","journal-title":"Acta Psychitr Scand"},{"issue":"11","key":"10.1016\/j.encep.2013.02.003_bib0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0006-3223(00)00963-X","article-title":"G-CSF plasma levels in clozapine-induced neutropenia","volume":"48","author":"Jauss","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eurpsy.2004.09.007","article-title":"Leucopenia in clozapine treated patients may be induced by other drugs: a case series","volume":"19","author":"Imbarlina","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0110","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1440-1614.2001.0911f.x","article-title":"Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine","volume":"35","author":"Pantelis","year":"2001","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/ajp.152.3.413","article-title":"Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228\u00a0patients at risk","volume":"152","author":"Tohen","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s002130051008","article-title":"Circadian rhythm of white blood cells during clozapine treatment","volume":"144","author":"Ahokas","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.encep.2013.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4088\/JCP.v65n0918a","article-title":"Two-year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia","volume":"65","author":"Esposito","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2013.02.003_bib0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2141.1999.01543.x","article-title":"Circadian variation of granulocyte colony stimulating factor levels in man","volume":"106","author":"Jilma","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.encep.2013.02.003_bib0135","first-page":"429","article-title":"Clozapine-induced transient white blood count disorders","volume":"55","author":"Hummer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/pgmj.2004.031161","article-title":"Agranulocytosis, and benign ethnic neutropenia","volume":"81","author":"Rajagopal","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.encep.2013.02.003_bib0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1099-1077(200006)15:4<275::AID-HUP171>3.0.CO;2-3","article-title":"A second trial of clozapine in a case of granulocytopenia","volume":"15","author":"Silvestrini","year":"2000","journal-title":"Hum Psycho-Pharmacol"},{"key":"10.1016\/j.encep.2013.02.003_bib0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.188.3.255","article-title":"Rechallenge with clozapine following leucopenia or neutropenia during previous therapy","volume":"188","author":"Dunk","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1192\/bjp.179.2.180","article-title":"An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia","volume":"179","author":"Conus","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.yic.0000062800.74434.6c","article-title":"Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis","volume":"18","author":"Hagg","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2013.02.003_bib0165","first-page":"256","article-title":"Filgrastim treatment of three patients with clozapine-induced agranulocytosis","volume":"56","author":"Lamberti","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1993.tb00789.x","article-title":"Recombinant human granulocyte colony- stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis","volume":"234","author":"Nielsen","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.encep.2013.02.003_bib0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230109147387","article-title":"Initiation of clozapine therapy in a patient with preexisting leucopenia: a discussion of the rationale of current treatment options","volume":"13","author":"Boshes","year":"2001","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.encep.2013.02.003_bib0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00023210-200721010-00003","article-title":"Restarting clozapine after neutropenia: evaluating the possibilities and practicalities","volume":"21","author":"Whiskey","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.encep.2013.02.003_bib0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hup.1056","article-title":"Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children","volume":"24","author":"Mattai","year":"2009","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"5","key":"10.1016\/j.encep.2013.02.003_bib0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1176\/appi.ajp.2009.09111560","article-title":"Clozapine rechallenge in refractory schizophrenia","volume":"167","author":"Chikezie","year":"2010","journal-title":"Am J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700613000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700613000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T10:00:07Z","timestamp":1539770407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700613000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":38,"alternative-id":["S0013700613000377"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2013.02.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}